Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KANZ, L")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 110

  • Page / 5
Export

Selection :

  • and

IDENTIFICATION OF HUMAN MAGAKARYOCYTES DERIVED FROM PURE MEGAKARYOCYTIC COLONIES (CFU-M), MEGAKARYOCYTIC-ERYTHROID COLONIES (CFU-M/E), AND MIXED HEMOPOIETIC COLONIES (CFU-GEMM) BY ANTIBODIES AGAINST PLATELET ASSOCIATED ANTIGENSKANZ L; STRAUB G; BROSS KG et al.1982; BLUT; ISSN 0006-5242; DEU; DA. 1982; VOL. 45; NO 4; PP. 267-274; BIBL. 25 REF.Article

SUPPRESSOR T-CELL CLONES DERIVED FROM PLURIPOTENT STEM CELLS (CFU-GEMM) OF A PATIENT WITH HODGKIN'S LYMPHOMAFAUSER AA; BROSS KG; KANZ L et al.1982; BLUT; ISSN 0006-5242; DEU; DA. 1982; VOL. 45; NO 2; PP. 97-102; BIBL. 13 REF.Article

DREIDIMENSIONALE DARSTELLUNG UND DIFFERENTIALDIAGNOSE VON ODONTOGENEN ZYSTEN = VISUALISATION TRIDIMENSIONNELLE ET DIAGNOSTIC DIFFERENTIEL DES KYSTES ODONTOGENESKANZ L; MITTERMAYER C; HAERLE F et al.1980; DTSCH. Z. MUND-KIEFER-GESICHTS.-CHIR.; ISSN 0343-3137; DEU; DA. 1980; VOL. 4; NO 4; PP. 198-204; ABS. ENG; BIBL. 13 REF.Article

Diagnosis and treatment of patients with testicular germ cell cancerHARTMANN, J. T; KANZ, L; BOKEMEYER, C et al.Drugs (Basel). 1999, Vol 58, Num 2, pp 257-281, issn 0012-6667Article

The management of primary mediastinal B-cell lymphoma with sclerosisBRUGGER, W; ENGELHARDT, R; MERTELSMANN, R et al.Annals of oncology. 1994, Vol 5, Num 10, pp 943-947, issn 0923-7534Article

Hematopoietic growth factors in peripheral blood progenitor cell transplantationHENSCHLER, R; BRUGGER, W; MERTELSMANN, R et al.Pathologie et biologie. 1994, Vol 42, Num 10, pp 968-969, issn 0369-8114Conference Paper

Management of cytomegalovirus infection after solid-organ or stem-cell transplantation : Current guidelines and future prospectsHEBART, H; KANZ, L; JAHN, G et al.Drugs (Basel). 1998, Vol 55, Num 1, pp 59-72, issn 0012-6667Article

Lymphokine(s) from isolated T lymphocyte subpopulations support multilineage hematopoietic colony and megakaryocytic colony formationKANZ, L; LÖHR, G. W; FAUSER, A. A et al.Blood. 1986, Vol 68, Num 5, pp 991-995, issn 0006-4971Article

In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cellsHERRMANN, F; BRUGGER, W; KANZ, L et al.Seminars in oncology. 1992, Vol 19, Num 4, pp 422-431, issn 0093-7754Article

The use of hematopoietic growth factor for high-dose chemotherapy and peripheral blood progenitor cell transplantationKANZ, L; BRUGGER, W; MERTELSMANN, R et al.Seminars in oncology. 1994, Vol 21, Num 6, pp 10-18, issn 0093-7754, SUP16Conference Paper

Stem cell mobilization. II: Critical issuesANDREESEN, R; KANZ, L.Bone marrow transplantation. Supplement (Basingstoke). 1993, Vol 12, Num 4, pp S126-S127, issn 0951-3078Conference Paper

Mobilization of peripheral blood progenitor cells by hemopoietic growth factors following standard dose chemotherapyKANZ, L; BRUGGER, W; MERTELSMANN, R et al.Bone marrow transplantation. Supplement (Basingstoke). 1992, Vol 10, Num 2, issn 0951-3078, p. 6Conference Paper

Immune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3/CD19 depleted graftsFEDERMANN, B; HAGELE, M; PFEIFFER, M et al.Leukemia. 2011, Vol 25, Num 1, pp 121-129, issn 0887-6924, 9 p.Article

Antisignal recognition particle-positive polymyositis successfully treated with myeloablative autologous stem cell transplantationHENES, J. C; HEINZELMANN, F; WACKER, A et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 3, pp 447-448, issn 0003-4967, 2 p.Article

Aktueller Stellenwert der Stammzelltransplantation bei Autoimmunerkrankungen = Current value of stem cell transplantation in autoimmune diseasesKÖTTER, I; SCHMALZING, M; HENES, J et al.Zeitschrift für Rheumatologie (Print). 2008, Vol 67, Num 8, pp 716-722, issn 0340-1855, 7 p.Article

Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapyKOLLMANNSBERGER, C; MAYER, F; KUCZYK, M et al.World journal of urology (Print). 2001, Vol 19, Num 2, pp 120-125, issn 0724-4983Article

Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screeningHEBART, H; LÖFFLER, J; SCHUMACHER, U et al.The Journal of infectious diseases. 2000, Vol 181, Num 5, pp 1713-1719, issn 0022-1899Article

Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancerBOKEMEYER, C; GERL, A; SCHÖFFSKI, P et al.Journal of clinical oncology. 1999, Vol 17, Num 2, pp 512-516, issn 0732-183XArticle

Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapiesBROSSART, P; HEINRICH, K. S; STUHLER, G et al.Blood. 1999, Vol 93, Num 12, pp 4309-4317, issn 0006-4971Article

Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer : A mature follow-up reportFETSCHER, S; BRUGGER, W; ENGELHARDT, R et al.Annals of oncology. 1999, Vol 10, Num 5, pp 561-567, issn 0923-7534Article

The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitorsBÜHRING, H.-J; SIMMONS, P. J; PUDNEY, M et al.Blood. 1999, Vol 94, Num 7, pp 2343-2356, issn 0006-4971Article

Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation) : results of a pilot studyWIESMANN, A; WELLER, A; LISCHKA, G et al.Bone marrow transplantation (Basingstoke). 1999, Vol 23, Num 2, pp 151-155, issn 0268-3369Article

Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignanciesKOLLMANNSBERGER, C; HARTMANN, J. T; KANZ, L et al.Journal of cancer research and clinical oncology. 1998, Vol 124, Num 3-4, pp 207-214, issn 0171-5216Article

Poor response rate to a continuous schedule of Amifostine therapy for 'low/intermediate risk' myelodysplastic patientsBOWEN, D. T; BRUGGER, C. D; CULLIGAN, D et al.British journal of haematology. 1998, Vol 103, Num 3, pp 785-787, issn 0007-1048Article

Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancerFETSCHER, S; BRUGGER, W; ENGELHARDT, R et al.Annals of oncology. 1997, Vol 8, Num 1, pp 49-56, issn 0923-7534Article

  • Page / 5